Segment Information and Concentration (Tables)

6 Months Ended

Jun. 30, 2024

Segment Information and Concentration

Schedule Of Segment Information

Three Months Ended June 30, 2024:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,281,900	$	365,400		$	-		$	2,647,300
Foreign Sales		629,800		205,700						835,500
Income (Loss) From Operations		214,500		(1,292,900	)		(257,800	)		(1,336,200	)
Assets		6,224,600		4,754,300			3,295,100			14,274,000
Long-Lived Asset Expenditures		24,100		600			-			24,700
Depreciation and Amortization		21,400		167,800			-			189,200

Three Months Ended June 30, 2023:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,614,300	$	368,200		$	-		$	2,982,500
Foreign Sales		723,200		139,900						863,100
Income (Loss) From Operations		215,400		(1,794,600	)		(647,000	)		(2,226,200	)
Assets		7,023,400		5,332,400			1,844,100			14,199,900
Long-Lived Asset Expenditures		17,000		43,400			-			60,400
Depreciation and Amortization		20,400		170,200			-			190,600

Six Months Ended June 30, 2024:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	4,449,300	$	681,500		$	-		$	5,130,800
Foreign Sales		1,284,900		406,200						1,691,100
Income (Loss) From Operations		287,300		(2,894,700	)		(818,300	)		(3,425,700	)
Assets		6,224,600		4,754,300			3,295,100			14,274,000
Long-Lived Asset Expenditures		69,900		2,300			-			72,200
Depreciation and Amortization		42,800		334,500			-			377,300

Six Months Ended June 30, 2023:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	5,196,500	$	591,400		$	-		$	5,787,900
Foreign Sales		1,579,800		235,800						1,815,600
Income (Loss) From Operations		481,600		(3,867,100	)		(1,308,300	)		(4,693,800	)
Assets		7,023,400		5,332,400			1,844,100			14,199,900
Long-Lived Asset Expenditures		25,200		81,000			-			106,200
Depreciation and Amortization		43,700		334,800			-			378,500

Schedule Of Reconciliation Of The Company's consolidated Segment Incomed Loss

For the three months ended June 30, 2024	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	214,500		$	(1,292,900	)	$	(257,800	)	$	(1,336,200	)
Other income(expense), net		(3,700	)		5,600			(3,900	)		(2,000	)
Interest income		-						54,600			54,600
Total other income(expense), net		(3,700	)		5,600			50,700			52,600
Income (Loss) from operations before discontinued operations and income taxes	$	210,800		$	(1,287,300	)	$	(207,100	)	$	(1,283,600	)
For the three months ended June 30, 2023	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	215,400		$	(1,794,600	)	$	(647,000	)	$	(2,226,200	)
Other income (expense), net		4,200			100			(200	)		4,100
Interest income		-			-			37,000			37,000
Total other income, net		4,200			100			36,800			41,100
Income (Loss) from operations before discontinued operations and income taxes	$	219,600		$	(1,794,500	)	$	(610,200	)	$	(2,185,100	)

For the six months ended June 30, 2024	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	287,300		$	(2,894,700	)	$	(818,300	)	$	(3,425,700	)
Other income(expense), net		(7,200	)		11,100			(10,200	)		(6,300	)
Interest income		-			-			96,800			96,800
Total other income(expense), net		(7,200	)		11,100			86,600			90,500
Income (Loss) from operations before discontinued operations and income taxes	$	280,100		$	(2,883,600	)	$	(731,700	)	$	(3,335,200	)
For the six months ended June 30, 2023	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	481,600		$	(3,867,100	)	$	(1,308,300	)	$	(4,693,800	)
Other income (expense), net		2,400			11,100			76,900			90,400
Interest income		-			-			46,400			46,400
Total other income, net		2,400			11,100			123,300			136,800
Income (Loss) from operations before discontinued operations and income taxes	$	484,000		$	(3,856,000	)	$	(1,185,000	)	$	(4,557,000	)